Notificatiob
Notificatiob
Caption
Find job vacancies
Phytomenadione

Phytomenadione

Material: There is 0.2 ml solution in each Ampole so that phytomenadione BP2 mg. Existing It is used for oral, IM, or IV (especially for children).

Instructions: Resistant to the newborn and used in hemoglobic conditions. Hemorrhage or its risk due to acute hypoprofibrinemia (lack of fatigue, fat, fat and), excessive use of the comerine antioxidants, phenyl beetzone and hypovitaminosis (jaundice, liver and intensity of inactivation, long-term antibiotics, sulfonamide, sulfonamide and Salicylate use). Vitamin K deficiency bleeding.

Doses: Moderate hemorrhage or hemorrhage tendency: In the case of newborns, usually with birth or slightly after 2m. GRA The levels are to be eaten in the mouth. Next 4th-5th, 2mg of day And on 28th-30th day more 2 mg Have to be fed in the mouth. Ivy / IM can be given at the same level if not fed to mouth. 5-10 mg for children under one year May be fed to the mouth. 

Side effects: Some anaphylactoid reactions and Venus eritation information are found in the use of phytomondine injection.

 Use during pregnancy and breastfeeding: Vitamin K-1 Placenta or very little amount of milk in the milk. The risk of disease and vitamin K-1 can be advised based on the requirements.
āωāĻĒাāĻĻাāύ : āĻĒ্āϰāϤিāϟি āĻ…্āϝাāĻŽ্āĻĒুāϞে āφāĻ›ে ā§Ļ.⧍ āĻŽি.āϞি āϏāϞিāωāĻļāύ āϝাāϤে āĻĢাāχāϟোāĻŽেāύāĻĄিāĻ“āύ āĻŦিāĻĒি ⧍ āĻŽি.āĻ—্āϰা. āĻŦিāĻĻ্āϝāĻŽাāύ। āĻāϟি āĻ“āϰাāϞ, āφāχāĻāĻŽ āĻ…āĻĨāĻŦা āφāχāĻ­ি āĻŦ্āϝāĻŦāĻšাāϰেāϰ āϜāύ্āϝ (āĻŦিāĻļেāώāϤঃ āĻļিāĻļুāĻĻেāϰ āϜāύ্āϝ āĻŦ্āϝāĻŦāĻšাāϰ্āϝ)।

āύিāϰ্āĻĻেāĻļāύা : āύāĻŦāϜাāϤāĻ•েāϰ āĻ•্āώেāϤ্āϰে āĻĒ্āϰāϤিāϰোāϧāĻ• āĻšিāϏাāĻŦে āĻ“ āĻšেāĻŽোāϰেāϜিāĻ• āĻ…āĻŦāϏ্āĻĨাāϝ় āĻŦ্āϝāĻŦāĻšাāϰ্āϝ। āϤীāĻŦ্āϰ āĻšাāχāĻĒোāĻĒ্āϰোāĻĨ্āϰāĻŽ্āĻŦিāύেāĻŽিāϝ়াāϰ (āĻ•্āϞāϟিং āĻĢ্āϝাāĻ•্āϟāϰ āĻ“āĻ“, āĻ āĻ“āĻ“, āĻ“āĻĸ āĻ“ x āĻāϰ āĻ…āĻ­াāĻŦ) āĻ•াāϰāύে āϏৃāώ্āϟ āĻšেāĻŽোāϰেāϜ āĻŦা āϤাāϰ āĻুঁāĻ•ি, āĻ•োāĻŽাāϰিāύ āϜাāϤীāϝ় āĻ…্āϝাāύ্āϟি āĻ•োāϝ়াāĻ—ুāϞেāύ্āϟেāϰ āĻ…āϤিāĻŽাāϤ্āϰাāϝ় āĻŦ্āϝāĻŦāĻšাāϰ, āĻĢিāύাāχāϞ āĻŦিāωāϟাāϜোāύ āĻāĻŦং āĻšাāχāĻĒোāĻ­িāϟাāĻŽিāύোāϏিāϏ-āĻ•ে (āϜāύ্āĻĄিāϏ, āϞিāĻ­াāϰ āĻ“ āχāύ্āϟেāϏāϟাāχāύেāϰ āĻ…āĻ•াāϰ্āϝāĻ•াāϰিāϤা, āĻĻীāϰ্āϘāĻŽেāϝ়াāĻĻী āĻ…্āϝাāύ্āϟিāĻŦাāϝ়োāϟিāĻ•, āϏাāϞāĻĢোāύাāĻŽাāχāĻĄ, āϏাāϞāĻĢোāύাāĻŽাāχāĻĄ āĻ“ āϏ্āϝাāϞিāϏাāχāϞেāϟেāϰ āĻŦ্āϝāĻŦāĻšাāϰ)। āĻ­িāϟাāĻŽিāύ āĻ•ে āĻāϰ āĻ…āĻ­াāĻŦāϜāύিāϤ āϰāĻ•্āϤāĻ•্āώāϰāĻŖে āĻŦ্āϝāĻŦāĻšাāϰ্āϝ।

āϏেāĻŦāύāĻŦিāϧি āĻ“ āĻŽাāϤ্āϰা : āĻŽৃāĻĻু āĻšেāĻŽোāϰেāϜ āĻŦা āĻšেāĻŽোāϰেāϜেāϰ āĻĒ্āϰāĻŦāĻŖāϤা: āύāĻŦāϜাāϤāĻ•েāϰ āĻ•্āώেāϤ্āϰে āϏাāϧাāϰāĻŖāϤ: āϜāύ্āĻŽেāϰ āϏāĻ™্āĻ—ে āϏāĻ™্āĻ—ে āĻŦা āϏাāĻŽাāύ্āϝ āĻĒāϰে ⧍ āĻŽি. āĻ—্āϰা. āĻŽাāϤ্āϰাāϝ় āĻŽুāĻ–ে āĻ–াāĻ“āϝ়াāϤে āĻšāϝ়। āĻĒāϰāĻŦāϰ্āϤীāϤে ā§Ēāϰ্āĻĨ-ā§ĢāĻŽ, āĻĻিāύে ⧍ āĻŽি.āĻ—্āϰা. āĻ“ ā§¨ā§Ž āϤāĻŽ- ā§Šā§ĻāϤāĻŽ āĻĻিāύে āφāϰো ⧍ āĻŽি.āĻ—্āϰা. āĻŽুāĻ–ে āĻ–াāĻ“āϝ়াāϤে āĻšāĻŦে। āĻŽুāĻ–ে āĻ–াāĻ“āϝ়াāύো āύা āĻ—েāϞে āφāχāĻ­ি/āφāχāĻāĻŽ āĻĒāĻĨে āĻāĻ•āχ āĻŽাāϤ্āϰাāϝ় āĻĻেāϝ়া āϝাāϝ়। āĻāĻ• āĻŦāĻ›āϰেāϰ āĻŦেāĻļি āĻŦāϝ়āϏেāϰ āĻļিāĻļুāϰ āĻ•্āώেāϤ্āϰে ā§Ģ-ā§§ā§Ļ āĻŽি.āĻ—্āϰা. āĻĒāϰ্āϝāύ্āϤ āĻŽুāĻ–ে āĻ–াāĻ“āϝ়াāύো āϝেāϤে āĻĒাāϰে।

āĻĒাāϰ্āĻļ্āĻŦ āĻĒ্āϰāϤিāĻ•্āϰিāϝ়া : āĻĢাāχāϟোāĻŽেāύাāĻĄিāĻ“āύ āχāĻž্āϜেāĻ•āĻļāύ āĻŦ্āϝāĻŦāĻšাāϰেāϰ āĻ•্āώেāϤ্āϰে āĻ•িāĻ›ু āĻ…্āϝাāύাāĻĢাāχāϞ্āϝাāĻ•āϟāϝ়েāĻĄ āĻĒ্āϰāϤিāĻ•্āϰিāϝ়া āĻ“ āĻ­েāύাāϏ āχāϰিāϟেāĻļāύ āĻāϰ āϤāĻĨ্āϝ āĻĒাāĻ“āϝ়া āĻ—েāĻ›ে।

āĻ—āϰ্āĻ­াāĻŦāϏ্āĻĨাāϝ় āĻ“ āϏ্āϤāύ্āϝāĻĻাāύāĻ•াāϞে āĻŦ্āϝāĻŦāĻšাāϰ : āĻ­িāϟাāĻŽিāύ āĻ•ে-ā§§ āĻĒ্āϞাāϏেāύ্āϟা āĻŦা āĻŽাāϝ়েāϰ āĻĻুāϧে āĻ–ুāĻŦ āĻ…āϞ্āĻĒ āĻĒāϰিāĻŽাāύে āĻĒ্āϰāĻŦেāĻļ āĻ•āϰে। āϰোāĻ—েāϰ āĻুঁāĻ•ি āĻ“ āĻ­িāϟাāĻŽিāύ āĻ•ে-ā§§ āĻāϰ āĻĒ্āϰāϝ়োāϜāύীāϝ়āϤাāϰ āωāĻĒāϰ āĻ­িāϤ্āϤি āĻ•āϰে āĻĒāϰাāĻŽāϰ্āĻļ āĻĻেāϝ়া āϝেāϤে āĻĒাāϰে।
Link copied to clipboard